Clinical Laserthermia Systems

Sweden
Lund, Skane Lan, Sweden
046-15 21 00 ★

Company profile

Clinical Laserthermia Systems company profile

Clinical Laserthermia Systems (CLS) develops and markets the TRANBERG®|Thermal Therapy System, as well as disposable materials and methods, for heat-induced immunotherapy enabling safe and gentle treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for CLS’ own immunostimulating therapy, imILT®. The company is headquartered in Lund, Sweden, with subsidiaries in Berlin, Germany and in Boston, USA. CLS is listed on Nasdaq First North under the stock symbol CLS B.

Business identity

Contact email
[email protected]
Phone number
046-15 21 00
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2006-01-01

Headquarters

Headquarters
Lund, Skane Lan, Sweden
Postal code
223 81
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
3
Total equity funding
$4.3M
Last funding
Post Ipo Equity / $2.2M / 2025-09-30
Last equity funding
Post Ipo Equity / $2.2M
Investors
1
Lead investors
1
Founders
3
Articles
92
Exited on
2024-04-26

Founders and investors

Founders

Karl Goran TranbergLars-Erik T. ErikssonPar H Henriksson

Lead investors

EISMEA

Investors

EISMEA

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.